Archive · 21 Jan 2026
IIT Roorkee Develops Advanced Antibody Discovery Platform
Scientists at IIT Roorkee have created a new tool to find special proteins called antibodies.
These antibodies can help detect and fight diseases like infections, cancer, and autoimmune disorders.
The tool is very big and diverse, which means it can find many different types of antibodies quickly.
This is important because it can help doctors and scientists respond faster to health emergencies.
The researchers worked with a company called IMGENEX India to make sure this new tool can be used in real life.
This development is part of India's plan to become self-reliant in healthcare and to help people who need affordable and timely medical solutions.
IIT Roorkee researchers developed an ultra-large, high-diversity single-domain antibody (nanobody) library.
The platform enables rapid identification of highly stable and high-affinity antibodies for various diseases.
The innovation aims to reduce discovery timelines and strengthen healthcare response during public health emergencies.
The research aligns with India's vision of Atmanirbhar Bharat and Make in India, focusing on low- and middle-income countries.
IIT Roorkee has collaborated with IMGENEX India for technology transfer, scale-up, and validation of antibody-based solutions.
- Who
- Researchers at IIT Roorkee
- What
- Developed a next-generation antibody discovery platform
- When
- Announced on Tuesday
- Where
- Indian Institute of Technology (IIT) Roorkee
- Why
- To transform diagnostics and therapeutics, especially for low- and middle-income countries
- Institution
- Indian Institute of Technology (IIT) Roorkee
- Platform Type
- Ultra-large, high-diversity single-domain antibody (nanobody) library
- Applications
- Infectious diseases, cancer, autoimmune disorders, emerging pathogens
- Key Benefit
- Rapid identification of highly stable and high-affinity antibodies
- Collaboration Partner
- IMGENEX India
- National Vision
- Atmanirbhar Bharat and Make in India
- Focus Areas
- Low- and middle-income countries, healthcare resilience, pandemic preparedness